Group B streptoccous 6-valent polysaccharide conjugate vaccine (Pfizer)

N/A

Report date: 2026/04/14 20:00:15

Base Information

Drug NameGroup B streptoccous 6-valent polysaccharide conjugate vaccine (Pfizer)
Drug Alias NameGBS infection vaccine - PfizerMultivalent Group B Streptococcus vaccine - PfizerPF-06760805GBS-6
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Conjugated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsStreptococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[14] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncSt Georges University of London
Inactive CompaniesN/A
Active IndicationsStreptococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A